NYSEAMERICAN:EMAN - eMagin Stock Price, Price Target & More

eMagin trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "EMAN."

eMagin Co. (NYSEAMERICAN:EMAN) released its quarterly earnings data on Thursday, May, 10th. The semiconductor company reported ($0.05) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.04) by $0.01. The semiconductor company earned $6.87 million during the quarter, compared to analysts' expectations of $6.50 million. eMagin had a negative return on equity of 57.13% and a negative net margin of 69.91%. View eMagin's Earnings History.

eMagin is scheduled to release their next quarterly earnings announcement on Thursday, August, 9th 2018. View Earnings Estimates for eMagin.

3 analysts have issued 12-month price objectives for eMagin's stock. Their forecasts range from $4.00 to $4.00. On average, they anticipate eMagin's share price to reach $4.00 in the next twelve months. View Analyst Ratings for eMagin.

eMagin saw a decrease in short interest during the month of May. As of May 31st, there was short interest totalling 1,223,182 shares, a decrease of 4.7% from the May 15th total of 1,283,783 shares. Based on an average trading volume of 81,562 shares, the days-to-cover ratio is presently 15.0 days. Approximately 3.4% of the company's stock are short sold.

Some companies that are related to eMagin include Manz (M5Z), Nanoco Group (NANO), CML Microsystems (CML), Trio-Tech International (TRT), Solitron Devices (SODI) and Terrascend (TER).

Press coverage about EMAN stock has been trending somewhat positive recently, Accern reports. The research firm identifies negative and positive press coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. eMagin earned a daily sentiment score of 0.09 on Accern's scale. They also assigned media stories about the semiconductor company an impact score of 46.07 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock's share price in the near term.

eMagin's stock is owned by a variety of of retail and institutional investors. Top institutional investors include First Washington CORP (3.13%), Penn Capital Management Co. Inc. (1.61%) and Northern Trust Corp (0.20%). Company insiders that own eMagin stock include Awm Investment Company, Inc, Jill Wittels, Stephen Costello and Stillwater Holdings Llc. View Institutional Ownership Trends for eMagin.

EMAN stock was acquired by a variety of institutional investors in the last quarter, including Penn Capital Management Co. Inc., First Washington CORP and Northern Trust Corp. Company insiders that have bought eMagin stock in the last two years include Jill Wittels, Stephen Costello and Stillwater Holdings Llc. View Insider Buying and Selling for eMagin.

Shares of EMAN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of EMAN stock can currently be purchased for approximately $1.90.

eMagin has a market capitalization of $67.82 million.

eMagin's mailing address is 2070 Route 52 Building 334, HOPEWELL JUNCTION, NY 12533-3507, United States. The semiconductor company can be reached via phone at +1-845-8387900.